Keryx UPDATE: Biopharmaceuticals Announces $90M Proposed Public Offering of Common Stock
January 21, 2014 at 16:23 PM EST
Keryx Biopharmaceuticals (Nasdaq: KERX ) today announced that it has commenced a $90 million underwritten public offering of shares of its common stock. In connection with this offering, Keryx expects to grant to the underwriters a 30-day option to purchase additional shares of common stock, equal to up
